IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.
Severe alpha(1)-antitrypsin (AAT) deficiency is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD), especially in individuals who smoke. There is marked variability in the development of lung disease in individuals homozygous (PI ZZ) for this autosomal recessive condition, suggesting that modifier genes could be important. We hypothesized that genetic determinants of obstructive lung disease may be modifiers of airflow obstruction in individuals with severe AAT deficiency. To identify modifier genes, we performed family-based association analyses for 10 genes previously associated with asthma and/or COPD, including IL10, TNF, GSTP1, NOS1, NOS3, SERPINA3, SERPINE2, SFTPB, TGFB1, and EPHX1. All analyses were performed in a cohort of 378 PI ZZ individuals from 167 families. Quantitative spirometric phenotypes included forced expiratory volume in one second (FEV(1)) and the ratio of FEV(1)/forced vital capacity (FVC). A qualitative phenotype of moderate-to-severe COPD was defined for individuals with FEV(1) </= 50 percent predicted. Six of 11 single-nucleotide polymorphisms (SNPs) in IL10 (P = 0.0005-0.05) and 3 of 5 SNPs in TNF (P = 0.01-0.05) were associated with FEV(1) and/or FEV(1)/FVC. IL10 SNPs also demonstrated association with the qualitative COPD phenotype. When phenotypes of individuals with a physician's diagnosis of asthma were excluded, IL10 SNPs remained significantly associated, suggesting that the association with airflow obstruction was independent of an association with asthma. Haplotype analysis of IL10 SNPs suggested the strongest association with IL10 promoter SNPs. IL10 is likely an important modifier gene for the development of COPD in individuals with severe AAT deficiency.
Demeo
Dawn L
DL
Brigham and Women's Hospital, Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115, USA. dawn.demeo@channing.harvard.edu
Campbell
Edward J
EJ
Barker
Alan F
AF
Brantly
Mark L
ML
Eden
Edward
E
McElvaney
N Gerard
NG
Rennard
Stephen I
SI
Sandhaus
Robert A
RA
Stocks
James M
JM
Stoller
James K
JK
Strange
Charlie
C
Turino
Gerard
G
Silverman
Edwin K
EK
D000328:Adult; D002648:Child; D015331:Cohort Studies; D005541:Forced Expiratory Volume / Q000235:genetics; D006239:Haplotypes; D006720:Homozygote; D006801:Humans; D016753:Interleukin-10 / Q000235:genetics*; D008175:Lung Neoplasms / Q000235:genetics / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D029424:Pulmonary Disease, Chronic Obstructive / Q000235:genetics* / Q000503:physiopathology; D012307:Risk Factors; D012907:Smoking / Q000235:genetics; D013147:Spirometry; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics; D000515:alpha 1-Antitrypsin / Q000235:genetics; D019896:alpha 1-Antitrypsin Deficiency / Q000150:complications / Q000235:genetics* / Q000503:physiopathology
C508609:IL10 protein, human; D014409:Tumor Necrosis Factor-alpha; D000515:alpha 1-Antitrypsin; D016753:Interleukin-10
Am J Respir Crit Care Med. 1997 Jul;156(1):68-74
9230728
Thorax. 2006 Jun;61(6):466-71
16517578
Am J Respir Crit Care Med. 1997 Nov;156(5):1436-9
9372657
Am J Hum Genet. 1998 Jul;63(1):259-66
9634505
Lancet. 1998 Jul 11;352(9122):113
9672280
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9465-70
9689103
Lab Invest. 1998 Sep;78(9):1077-87
9759652
Am J Respir Crit Care Med. 1998 Dec;158(6):1958-62
9847292
Eur Respir J. 1999 Aug;14(2):309-14
10515406
Thorax. 1999 Aug;54(8):693-6
10413721
Am J Respir Cell Mol Biol. 1999 Mar;20(3):441-7
10030842
Tissue Antigens. 2005 Jan;65(1):93-100
15663746
Chest. 2005 May;127(5):1537-43
15888825
Pediatrics. 2006 Aug;118(2):710-6
16882827
J Biol Chem. 2007 Mar 23;282(12):8573-82
17261591
Thorax. 2007 Sep;62(9):806-13
17389752
Clin Exp Allergy. 1999 Dec;29 Suppl 4:39-41
10641565
Hum Hered. 2000 Jul-Aug;50(4):211-23
10782012
Am J Respir Crit Care Med. 2000 May;161(5):1437-42
10806136
Biochem Biophys Res Commun. 2000 Jun 7;272(2):391-4
10833424
Eur J Clin Invest. 2000 Jun;30(6):543-8
10849024
Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1355-60
11029344
Am J Respir Crit Care Med. 2001 Feb;163(2):420-2
11179116
Am J Respir Crit Care Med. 2001 Feb;163(2):469-73
11179124
J Immunol. 2001 Mar 15;166(6):3915-22
11238636
Eur Respir J. 2001 Sep;18(3):482-90
11589345
Hum Genet. 2001 Dec;109(6):623-7
11810274
Am J Respir Crit Care Med. 2002 Jul 1;166(1):43-6
12091169
Am J Respir Crit Care Med. 2002 Aug 1;166(3):323-8
12153964
Chest. 2002 Aug;122(2):416-20
12171811
Dis Markers. 2002;18(3):129-36
12515908
Clin Exp Allergy. 2003 Jan;33(1):78-83
12534553
Chest. 2003 Mar;123(3):765-71
12628876
J Clin Lab Anal. 2003;17(5):168-73
12938145
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Dec;20(6):504-7
14669219
Am J Respir Crit Care Med. 2004 Jan 15;169(2):214-9
14597484
Am J Hum Genet. 2004 Feb;74(2):367-9
14740322
Genet Epidemiol. 2004 Feb;26(2):155-65
14748015
Hum Mol Genet. 2004 Feb 15;13(4):397-403
14681301
Thorax. 2004 Feb;59(2):126-9
14760152
Hum Mol Genet. 2004 Aug 1;13(15):1649-56
15175276
Am Rev Respir Dis. 1978 Dec;118(6 Pt 2):1-120
742764
Am Rev Respir Dis. 1981 Jun;123(6):659-64
7271065
Am J Hum Genet. 1987 Nov;41(5):891-906
2890296
Genomics. 1993 Sep;17(3):740-3
8244391
Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 2):S160-4
7952653
Am J Respir Crit Care Med. 1995 Sep;152(3):1107-36
7663792
J Allergy Clin Immunol. 1996 Jun;97(6):1288-96
8648025
Am J Physiol. 1996 Oct;271(4 Pt 1):L566-71
8897903
Eur J Immunogenet. 1997 Feb;24(1):1-8
9043871
Hum Mol Genet. 1997 Apr;6(4):551-4
9097957
Am J Respir Crit Care Med. 2005 Sep 15;172(6):687-92
15976383
N Engl J Med. 2005 Oct 6;353(14):1443-53
16207846
Nat Genet. 2005 Nov;37(11):1217-23
16244653
Am J Hum Genet. 2006 Feb;78(2):253-64
16358219
Nat Rev Genet. 2006 May;7(5):385-94
16619052
Am J Respir Crit Care Med. 2006 May 1;173(9):977-84
16456143
Am J Respir Crit Care Med. 2006 May 1;173(9):970-6
16456144
Lancet. 1997 Aug 30;350(9078):630-3
9288046